This alignment with KDIGO-defined criteria and established AKI biomarkers (serum creatinine, BUN, and NGAL) increases the translational impact of our findings and positions our study within the broader framework of AKI biomarker research. The gene discussed is LCN2; the disease is acute kidney injury.